Market Overview

Bard Declares Quarterly Dividend


The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a
regular quarterly dividend of 26 cents per share on Bard's common stock.
In connection with the pending merger with Becton, Dickinson & Company,
the quarterly dividend will be payable on December 29, 2017 to
shareholders of record at the close of business on December 8, 2017.

C. R. Bard, Inc. (,
headquartered in Murray Hill, NJ, is a leading multinational developer,
manufacturer and marketer of innovative, life-enhancing medical
technologies in the fields of vascular, urology, oncology and surgical
specialty products.

This press release may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995, which
are based on management's current expectations, the accuracy of which is
necessarily subject to risks and uncertainties. These statements are not
historical in nature and use words such as "anticipate", "estimate",
"expect", "project", "intend", "forecast", "plan", "believe", and other
words of similar meaning in connection with any discussion of future
operating or financial performance. Many factors may cause actual
results to differ materially from anticipated results including product
developments, sales efforts, income tax matters, the outcomes of
contingencies such as legal proceedings, and other economic, business,
competitive and regulatory factors. The company undertakes no obligation
to update its forward-looking statements. Please refer to the Cautionary
Statement Regarding Forward-Looking Information in our June 30, 2017
Form 10-Q for more detailed information about these and other factors
that may cause actual results to differ materially from those expressed
or implied.

View Comments and Join the Discussion!